Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru

Coralith García, Veerle Lejon, Gertrudis Horna, Lizeth Astocondor, Raymond Vanhoof, Sophie Bertrand, Jan Jacobs

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Thirty-three Salmonella enterica serovar Typhi blood isolates from Lima, Peru (2008 to 2012), were fully susceptible to trim-ethoprim-sulfamethoxazole, chloramphenicol, ceftriaxone, and tetracycline; 8/33 (24.2%) showed intermediate susceptibility to ciprofloxacin carrying mutations in the quinolone resistance-determining region of the gyrA gene (Ser83-Phe and Asp87-Asn) and in the gyrB gene (Ser464-Phe).

Original languageEnglish (US)
Pages (from-to)968-970
Number of pages3
JournalJournal of Clinical Microbiology
Volume52
Issue number3
DOIs
StatePublished - Mar 2014

    Fingerprint

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

García, C., Lejon, V., Horna, G., Astocondor, L., Vanhoof, R., Bertrand, S., & Jacobs, J. (2014). Intermediate susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates in Lima, Peru. Journal of Clinical Microbiology, 52(3), 968-970. https://doi.org/10.1128/JCM.02663-13